Jennifer Q. Dong

发表

Challenges in Drug Development Posed by the COVID‐19 Pandemic: An Opportunity for Clinical Pharmacology

K. Venkatakrishnan, O. Yalkinoglu, Jennifer Q. Dong, 2020, Clinical pharmacology and therapeutics.

Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series

R. Bergman, C. Cobelli, C. Dalla Man, 2016, Diabetes Care.

Once-weekly administration of a long-acting FGF 21 analogue modulates lipids , bone turnover markers , blood pressure , and body weight differently in obese hypertriglyceridemic subjects and in non-human primates

Jeffrey R. Chabot, T. Rolph, Y. Weng, 2017 .

Evobrutinib, a covalent Bruton’s tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants

A. Port, H. Scheible, J. V. van Lier, 2021, Clinical and translational science.

Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies

K. Venkatakrishnan, J. Bolleddula, S. Gopalakrishnan, 2022, Clinical and translational science.

Glucuronidation and Covalent Protein Binding of Benoxaprofen and Flunoxaprofen in Sandwich-Cultured Rat and Human Hepatocytes

Jennifer Q. Dong, Philip C. Smith, 2009, Drug Metabolism and Disposition.

Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans

A. Kalgutkar, L. Di, B. Feng, 2016, Drug Metabolism and Disposition.

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.

Jeffrey R. Chabot, J. Trimmer, T. Rolph, 2016, Cell metabolism.

Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome

Jeffrey R. Chabot, A. Kalgutkar, L. Buckbinder, 2017, Drug Metabolism and Disposition.

Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo.

Philip C Smith, Jianhua Liu, Jennifer Q Dong, 2005, Biochemical pharmacology.

Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies

D. Salinger, C. Endres, E. Hurh, 2011, Clinical pharmacokinetics.

Once‐weekly administration of a long‐acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non‐human primates

Jeffrey R. Chabot, T. Rolph, Y. Weng, 2017, Diabetes, obesity & metabolism.

Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study.

Yali Liang, D. Baltrukonis, Jennifer Q. Dong, 2015, British journal of clinical pharmacology.

DMD067868 209..219

A. Kalgutkar, M. Varma, S. Terra, 2016 .

Pharmacokinetics/pharmacodynamics model-supported early drug development.

Bin Chen, Jennifer Q. Dong, W. Pan, 2012, Current pharmaceutical biotechnology.

Risk assessment of drug–drug interaction potential for bintrafusp alfa with cytochrome P4503A4 substrates: A totality of evidence approach

K. Venkatakrishnan, Y. Vugmeyster, P. A. Rolfe, 2022, Clinical and translational science.

R. Bergman, C. Cobelli, M. Staten, 2016, Diabetes Care.

Pharmacokinetics of Ibuprofen Enantiomers in Children with Cystic Fibrosis

Liyun Ni, Jennifer Q. Dong, G. Retsch-Bogart, 2000, Journal of clinical pharmacology.

Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits.

S. Whitcup, D. Welty, D. Tang-Liu, 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need

Akash Khandelwal, Jennifer Q. Dong, L. Klopp-Schulze, 2022, Clinical pharmacology and therapeutics.